EndoQuest, an endoluminal robotics technology company, announced it closed a $42 million C-1 preferred financing round. Existing investors CE Ventures Limited and McNair Interests Ltd. participated in ...
Houston, TX, Sept. 25, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, today announced the completion of the first procedure ...
EndoQuest Robotics commences its PARADIGM clinical trial with endoscopic submucosal dissection procedures at HCA Houston Healthcare Medical Center Houston, TX, May 15, 2025 (GLOBE NEWSWIRE) -- ...
EndoQuest Robotics, Inc., is developing the Endoluminal Surgical (ELS) System, the world's first flexible endoluminal robotic surgical system, to provide therapeutic endoscopists and surgeons the ...
New Endoluminal Surgical Simulator highlights commitment to support professional training in advancing innovative technology for endoluminal robotic surgeries. HOUSTON, TX & ZURICH, SWITZERLAND / ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min EndoQuest's flexible endoscopy ...
HOUSTON, Jan. 5, 2024 /PRNewswire/ -- EndoQuest™ Robotics, Inc., a privately-held medical device company and pioneering leader in the development of innovative endoluminal robotic technologies, and ...
EndoQuest Robotics Secures Series D-2 Funding Round co-led by Crescent Enterprises and Dr. Fred Moll
Houston, TX, July 14, 2025 (GLOBE NEWSWIRE) -- EndoQuest Robotics, Inc., a pioneering leader in endoluminal robotic surgical technology, announced today that it has successfully closed a Series D-2 ...
HOUSTON, TX / ACCESSWIRE / January 25, 2023 / EndoQuest Robotics today announced that Dr. Todd Wilson has joined the company as Chief Medical Officer. In this role, Dr. Wilson will lead EndoQuest's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback